Equities

Youcare Pharmaceutical Group Co Ltd

688658:SHH

Youcare Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)16.55
  • Today's Change0.93 / 5.95%
  • Shares traded3.08m
  • 1 Year change-2.30%
  • Beta1.2304
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Youcare Pharmaceutical Group Co Ltd's revenues fell -7.61% from 4.54bn to 4.20bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 335.01m to 184.80m, a -44.84% decrease.
Gross margin57.15%
Net profit margin2.45%
Operating margin3.59%
Return on assets1.65%
Return on equity2.66%
Return on investment2.48%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Youcare Pharmaceutical Group Co Ltd fell by 144.81m. However, the company earned 785.49m from its operations for a Cash Flow Margin of 18.72%. In addition the company used 502.05m on investing activities and also paid 432.19m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share8.04
Tangible book value per share7.02
More ▼

Balance sheet in CNYView more

Youcare Pharmaceutical Group Co Ltd has a Debt to Total Capital ratio of 19.77%, a higher figure than the previous year's 0.95%.
Current ratio1.82
Quick ratio1.40
Total debt/total equity0.247
Total debt/total capital0.1977
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -81.82% and -44.93%, respectively. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)2.16%
Div growth rate (5 year)--
Payout ratio (TTM)92.62%
EPS growth(5 years)-26.33
EPS (TTM) vs
TTM 1 year ago
-76.06
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.